CHAMPIONS ONCOLOGY, INC. (CSBR) Revenue 2018–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$59.4MFY2026 · since FY2018: $20.2M → $59.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $59.4M | +4.4% |
| FY2025 | $56.9M | +13.5% |
| FY2024 | $50.2M | -6.9% |
| FY2023 | $53.9M | +9.7% |
| FY2022 | $49.1M | +19.7% |
| FY2021 | $41.0M | +27.8% |
| FY2020 | $32.1M | +18.7% |
| FY2019 | $27.1M | +33.7% |
| FY2018 | $20.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR Net incomeCSBR Net marginCSBR Gross profitCSBR Gross marginCSBR Operating incomeCSBR Operating marginCSBR Operating cash flowCSBR Free cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Total liabilitiesCSBR Shareholders’ equityCSBR overview →